Author:
Jiang Xiaoqian,Qu Aihua,Xu Xinxin,Kuang Hua,Liu Liqiang,Xu Chuanlai
Publisher
Springer Science and Business Media LLC
Reference66 articles.
1. Anderson, J. E.; Trujillo, M.; McElroy, T.; Groves, T.; Alexander, T.; Kiffer, F.; Allen, A. R. Early effects of cyclophosphamide, methotrexate, and 5-fluorouracil on neuronal morphology and hippocampal-dependent behavior in a murine model. Toxicol. Sci. 2020, 173, 156–170.
2. Kunnuru, S. K. R.; Thiyagarajan, M.; Daniel, J. M.; Balaji, S. K. A study on clinical and pathological responses to neoadjuvant chemotherapy in breast carcinoma. Breast Cancer: Targets Ther. 2020, 12, 259–266.
3. Mariani, G.; Galli, G.; Cavalieri, S.; Valagussa, P.; Bianchi, G. V.; Capri, G.; Cresta, S.; Ferrari, L.; Damian, S.; Duca, M.; et al. Single institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study. Breast J. 2019, 25, 237–242.
4. Li, Q.; Yang, Z.; Fan, J. H.; He, J. J.; Zhang, B.; Yang, H. J.; Xie, X. M.; Tang, Z. H.; Li, H.; Qiao, Y. L. et al. A nation-wide multicenter 10-year (1999–2008) retrospective study of chemotherapy in Chinese breast cancer patients. Oncotarget 2017, 8, 75864–75873.
5. Saloustros, E.; Malamos, N.; Boukovinas, I.; Kakolyris, S.; Kouroussis, C.; Athanasiadis, A.; Ziras, N.; Kentepozidis, N.; Makrantonakis, P.; Polyzos, A. et al. Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: A multicenter randomized study of the Hellenic Oncology Research Group (HORG). Breast Cancer Res. Treat. 2014, 148, 591–597.